Dr. Carpten currently serves as Professor and Chair for the Department of Translational Genomics, and Director of the Institute for Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA.
The primary goal of Dr. Carpten’s research program is to discover molecular alterations in cancer and to translate these findings into new approaches for prevention, diagnosis, and treatment. In support of this goal, his program is actively involved in the development and application of cutting edge technologies and novel bioinformatics approaches for discovery research. His work has impacted our understanding of a variety of cancer types including prostate cancer, breast cancer, colon cancer, brain cancer, multiple myeloma, and pediatric cancers.
Dr. Carpten was named a Science Trailblazer by Spectrum Magazine in 2006, awarded the Susan G. Komen Distinguished Lectureship on the Science of Cancer Health Disparities in 2014, and awarded the 2018 AACR MICR Jane Cooke Wright Lectureship for his outstanding research in cancer disparities and his efforts in developing the careers of minority scientists.
The Impact of Heterogeneity in Cancer Genome Science
Friday, November 15
1:00 p.m. – 1:45 p.m.